Objective RANGER addresses the HEALTH-2007-2.3.3-4: Innovative point-of-care (POC) diagnostic tests for influenza call by providing a innovative solution to the immediate need for a rapid, robust, cost effective & user friendly POC diagnostic for influenza. We will develop the following real-time PCR system: 1) A robust, portable system allowing testing at the POC anywhere in the world 2) Raw sample to result automation of the entire test process including sample preparation 3) Parallel processing of multiple samples & different sample types (aspirates & swabs) in a modular, user-friendly system 4) RAPID & simple positive/negative result to the end user 5) No need for an external computer or laboratory equipment 6) Low cost consumable & reagents with a target cost of < €10 per test 7) Sample preparation & freeze dried reagents pre-packaged into an ambient stable consumable to eliminate cold storage chains 8) High confidence PCR results providing sensitivity & specificity equivalent to reference laboratory assays a. Suitable for the diagnosis of early stage infections where viral titres can be low b. Applicable to late surveillance & can be used to confirm the results from lower cost, low performance screen tests such as antibody assays that have low sensitivity and specificity. c. Simultaneous identification of specific influenza strains & viral subtypes using multiplexing real-time PCR assays will also allow exclusion of related respiratory diseases 9) Surveillance Management software & geographical data using GPS, allowing health authorities to manage early stage epidemics. The RANGER consortium includes WHO reference sites for human influenza diagnostics & world leading companies to develop and validate a POC influenza diagnostic system within 2 years. This system will allow health systems to be better prepared for epidemics by enabling early identification of infection and thus timely implementation of containment/treatment strategies. Fields of science natural sciencescomputer and information sciencessoftwaresocial sciencessociologyindustrial relationsautomationmedical and health scienceshealth sciencesinfectious diseasesRNA virusesinfluenzamedical and health scienceshealth sciencesinfectious diseasesRNA virusescoronaviruses Keywords PCR POC Polymerase Chain Reaction influenza molecular diagnostics Programme(s) FP7-HEALTH - Specific Programme "Cooperation": Health Topic(s) HEALTH-2007-2.3.3-4 - Innovative point-of-care diagnostic tests for influenza Call for proposal FP7-HEALTH-2007-A See other projects for this call Funding Scheme CP-TP - Collaborative Project targeted to a special group (such as SMEs) Coordinator ENIGMA DIAGNOSTICS LIMITED EU contribution € 1 315 834,00 Address TETRICUS SCIENCE PARK PORTON DOWN Building 224 SP4 0JQ SALISBURY United Kingdom See on map Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Administrative Contact Ian George (Dr.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data Participants (8) Sort alphabetically Sort by EU Contribution Expand all Collapse all Tico Europe Limited Participation ended United Kingdom EU contribution € 31 736,00 Address SIDNEY STREET 80 CT19 6HQ FOLKESTONE See on map Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Administrative Contact Daniel Van Akkeren (Mr.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data HEALTH PROTECTION AGENCY HPA United Kingdom EU contribution € 468 451,00 Address BUCKINGHAM PALACE ROAD 151 SW1W 9SZ London See on map Activity type Research Organisations Administrative Contact Tim Brooks (Dr.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data BRUHN NEWTECH AS Denmark EU contribution € 62 850,00 Address VANDTARNSVEJ 62 A, 1. A. 2860 SOBORG See on map Region Danmark Hovedstaden Københavns omegn Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Administrative Contact Paul Taylor (Mr.) Links Contact the organisation Opens in new window Total cost No data QUEEN SIRIKIT NATIONAL INSTITUTE OF CHILD HEALTH Thailand EU contribution € 209 557,00 Address 420/8 Rajavithi Road, Rajthevi 10400 BANGKOK See on map Activity type Research Organisations Administrative Contact Tawee Chotpitayasunondh (Dr.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data BIOPLASTICS BV Netherlands EU contribution € 160 841,00 Address ROTSCHERWEG 61 6374 XW LANDGRAAF See on map Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Administrative Contact Tom Hendrikx (Mr.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data SAGENTIA GROUP LIMITED United Kingdom EU contribution € 431 090,00 Address HARSTON MILL CB22 7GG HARSTON CAMBRIDGE See on map Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Administrative Contact Daniel Flicos (Mr.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data PERA INNOVATION LIMITED United Kingdom EU contribution € 225 529,00 Address Innovation Park, Nottingham Road LE13 OPB MELTON MOWBRAY, LEICESTERSHIRE See on map Activity type Research Organisations Administrative Contact Lydia Lepecuchel (Dr.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data BIOPHARMA TECHNOLOGY LTD United Kingdom EU contribution € 76 312,00 Address WINNALL VALLEY ROAD 9 SO23 0LD WINCHESTER See on map Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Administrative Contact Andrew Cowen (Mr.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data
